Mengjing Bao

Dr. Mengjing Bao

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2012 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FLFen-Fen Li
Fen-Fen Li
JSJian Shen
Jian Shen
HSHui-Juan Shen
Hui-Juan Shen
XZXue Zhang
Xue Zhang
RCRui Cao
Rui Cao
YKYuehai Ke
Yuehai Ke
Cigarette smoke (CS), the major cause of chronic obstructive pulmonary disease, contains a variety of oxidative components that were implicated in the regulation of Src homology domain 2-containing protein tyrosine phosphatase 2 (Shp2) activity. However, the contribution of Shp2 enzyme to chronic obstructive pulmonary disease pathogenesis remains unclear. We investigated the role of Shp2 enzyme in blockading CS-induced pulmonary inflammation. Shp2 levels were assessed in vivo and in vitro. Mice (C57BL/6) or pulmonary epithelial cells (NCI-H292) were exposed to CS or cigarette smoke extract (CSE) to induce acute injury and inflammation. Lungs of smoking mice showed increased levels of Shp2, compared with those of controls. Treatment of lung epithelial cells with CSE showed elevated levels of Shp2 associated with the increased release of IL-8. Selective inhibition or knockdown of Shp2 resulted in decreased IL-8 release in response to CSE treatment in pulmonary epithelial cells. In comparison with CS-exposed wild-type mice, selective inhibition or conditional knockout of Shp2 in lung epithelia reduced IL-8 release and pulmonary inflammation in CS-exposed mice. In vitro biochemical data correlate CSE-mediated IL-8 release with Shp2-regulated epidermal growth factor receptor/Grb-2–associated binders/MAPK signaling. Our data suggest an important role for Shp2 in the pathological alteration associated with CS-mediated inflammation. Shp2 may be a potential target for therapeutic intervention for inflammation in CS-induced pulmonary diseases.

1 June 2011 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
YGYan Guan
Yan Guan
LFLi Fenfen
Li Fenfen
LHLing Hong
Ling Hong
XYXiao‐Feng Yan
Xiao‐Feng Yan
GTGong‐Li Tan
Gong‐Li Tan
QXQiang-Min Xie
Qiang-Min Xie

1 March 2011 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RCRui Cao
Rui Cao
XDXin-Wei Dong
Xin-Wei Dong
JJJun-Xia Jiang
Jun-Xia Jiang
XYXiao-Feng Yan
Xiao-Feng Yan
JHJun-Shan He
Jun-Shan He
QXQiang-Min Xie
Qiang-Min Xie

1 January 2013 in Nutrition
Verified
Journal Article
Closed access
MBMengjing Bao
Mengjing Bao
JSJian Shen
Jian Shen
YJYong-Liang Jia
Yong-Liang Jia
FLFen-Fen Li
Fen-Fen Li
WMWen-Jiang Ma
Wen-Jiang Ma
QXQiang-Min Xie
Qiang-Min Xie

Verified
Journal Article
Open access
MBMengjing Bao
Mengjing Bao
MGMathias Gempeler
Mathias Gempeler
Remo CampicheRemo Campiche
Remo Campiche
Achieving even skin tone and controlling pigmentation are key goals in dermocosmetics, given the impact of disorders like melasma, post-inflammatory hyperpigmentation, and age spots. The process of pigmentation begins with melanin synthesis within melanosomes, specialized organelles in melanocytes. Once produced, melanin is transferred to neighboring keratinocytes, where it forms protective caps over cell nuclei before undergoing eventual degradation. Disruptions at any stage of this complex process, whether in melanin production, melanosome transport, or post-transfer processing, can lead to visible pigmentation irregularities. While traditional treatments primarily focus on inhibiting melanin production (e.g., through tyrosinase inhibitors), emerging research highlights the important role of melanosome transport and keratinocyte-mediated processing in determining visible pigmentation. This review focuses on the underexplored stages of melanosome transport, transfer, and keratinocyte-mediated processing as promising targets for therapeutic and cosmetic strategies in managing pigmentation disorders.

1 March 2011 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JJJun-Xia Jiang
Jun-Xia Jiang
RCRui Cao
Rui Cao
WDWan-Ding Deng
Wan-Ding Deng
FJFang Jin
Fang Jin
XDXin-Wei Dong
Xin-Wei Dong
QXQiang-Min Xie
Qiang-Min Xie